Expression of the stem cell factor receptor c-kit (CD117) in acute leukemias

Haematologica

Volumn 82, Issue 5, 1997, Pages 617-621

  Sperling, Christian ^a   Schwartz, Stefan ^b   Büchner, Thomas ^c   Thiel, Eckhard ^b   Ludwig, Wolf Dieter ^a,d  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Section of Pathology   (Germany)

Author keywords

Acute lymphoblastic leukemia; Acute myeloid leukemia; C kit; CD 117

Indexed keywords

CD34 ANTIGEN; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; CANCER CLASSIFICATION; CELLULAR DISTRIBUTION; HEMATOPOIESIS; HUMAN; REVIEW;

ACUTE DISEASE; ADULT; HEMATOPOIESIS; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOID; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 0031437680     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Small D, Levenstein M, Kim E, et al. STK-1, the human homologue of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 1994; 91:459-63.
2. Rosnet O, Birnbaum D. Hematopoietic receptors of class III receptor-type tyrosine kinases. Crit Rev Oncog 1993; 4:595-613.
3. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61:203-12.
4. Yarden Y, Kuang WJ, Yang Feng T, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6:3341-51.
5. Giebel LB, Strunk KM, Holmes SA, Spritz RA. Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 1992; 7:2207-17.
6. André C, d'Auriol L, Lacombe C, Gisselbrecht S, Galibert F. c-kit mRNA expression in human and murine hematopoietic cell lines. Oncogene 1989; 4:1047-9.
7. Hu ZB, Ma W, Uphoff CC, Quentmeier H, Drexler HG. c-kit expression in human megakaryoblastic leukemia cell lines. Blood 1994; 83:2133-44.
8. deCastro CM, Denning SM, Langdon S, et al. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8-(triple-negative) thymocytes. Exp Hematol 1994; 22:1025-33.
9. Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem 1994; 42:1417-25.
10. Chui X, Egami H, Yamashita J, et al. Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. Br J Cancer 1996; 73:1233-6.
11. Hibi K, Takahashi T, Sekido Y, et al. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 1991; 6:2291-6.
12. Sekido Y, Takahashi T, Ueda R, et al. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Cancer Res 1993; 53:1709-14.
13. Krystal GW, Hines SJ, Organ CP. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res 1996; 56:370-6.
14. Hines SJ, Organ C, Kornstein MJ, Krystal GW. Coexpression of the c-kit and stem cell factor genes in breast carcinomas. Cell Growth Differ 1995; 6:769-79.
15. Ohashi A, Funasaka Y, Ueda M, Ichihashi M. c-kit receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res 1996; 6:25-30.
16. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992; 80:374-81.
17. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994; 55:1-96.
18. McCulloch EA, Minden MD. The cell surface receptor encoded by the proto-oncogene KIT and its ligand. Cancer Treat Res 1993; 64:45-77.
19. Gadd SJ, Ashman LK. A murine monoclonal antibody specific for a cell-surface antigen expressed by a subgroup of human myeloid leukemias. Leuk Res 1985; 9:1329-36.
20. Lerner NB, Nocka KH, Cole SR, et al. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991; 77:1876-83.
21. Broudy VC, Lin N, Zsebo KM, et al. Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 1992; 79:338-46.
22. Bühring HJ, Ullrich A, Schaudt K, Müller CA, Busch FW. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991; 5:854-60.
23. Morita S, Tsuchiya S, Fujie H, et al. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture. Leukemia 1996; 10:102-5.
24. Ashman LK, Bühring HJ, Aylett GW, Broudy VC, Müller C. Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1. J Cell Physiol 1994; 158:545-54.
25. Ashman LK, Cambareri AC, To LB, Levinsky RJ, Juttner CA. Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 1991; 78:30-7.
26. Strobl H, Takimoto M, Majdic O, Hocker P, Knapp W. Antigenic analysts of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. Br J Haematol 1992; 82:287-94.
27. Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture. Exp Hematol 1994; 22:157-65.
28. high cells. Blood 1993; 82:3283-9.
29. McNiece IK, Langley KE, Zsebo KM. Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 1991; 19:226-31.
30. Broxmeyer HE, Maze R, Miyazawa K, et al. The kit receptor and its ligand, steel factor, as regulators of hemopoiesis. Cancer Cells 1991; 3:480-7.
31. Kinashi T, Springer TA. Steel factor and c-kit regulate cell-matrix adhesion. Blood 1994; 83:1033-8.
32. Rolink A, Streb M, Nishikawa S, Melchers F. The c-kit-encoded tyrosine kinase regulates the proliferation of early pre-B cells. Eur J Immunol 1991; 21:2609-12.
33. Palacios R, Nishikawa S. Developmentally regulated cell surface expression and function of c-kit receptor during lymphocyte ontogeny in the embryo and adult mice. Development 1992; 115:1133-47.
34. Rico-Vargas SA, Weiskopf B, Nishikawa S, Osmond DG. c-kit expression by B cell precursors in mouse bone marrow. Stimulation of B cell genesis by in vivo treatment with anti-c-kit antibody. J Immunol 1994; 152:2845-52.
35. Rolink A, Melchers F. Generation and regeneration of cells of the B-lymphocyte lineage. Curr Opin Immunol 1993; 5:207-17.
36. Takeda S, Shimizu T, Rodewald HR. Interactions between c-kit and stem cell factor are not required for B-cell development in vivo. Blood 1997; 89:518-25.
37. McNiece IK, Langley KE, Zsebo KM. The role of recombinant stem cell factor in early B cell development. Synergistic interaction with IL-7. J Immunol 1991; 146:3785-90.
38. Billips LG, Petitte D, Dorshkind K, Narayanan R, Chiu CP, Landreth KS. Differential roles of stromal cells, interleukin-7, and kit-ligand in the regulation of B lymphopoiesis. Blood 1992; 79:1185-92.
39. Funk PE, Varas A, Witte PL. Activity of stem cell factor and IL-7 in combination on normal bone marrow B lineage cells. J Immunol 1993; 150:748-52.
40. Wolf SS, Cohen A. Expression of cytokines and their receptors by human thymocytes and thymic stromal cells. Immunology 1992; 77:362-8.
41. Morrissey PJ, McKenna H, Widmer MB, et al. Steel factor (c-kit ligand) stimulates the in vitro growth of immature CD3-/CD4-/CD8-thymocytes: synergy with IL-7. Cell Immunol 1994; 157:118-31.
42. Siitonen T, Savolainen ER, Koistinen P. Expression of the c-kit protooncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia 1994; 8:631-7.
43. Muroi K, Nakamura M, Amemiya Y, Suda T, Miura Y. Expression of c-kit receptor (CD117) and CD34 in leukemic cells. Leuk Lymphoma 1995; 16:297-305.
44. Valverde LR, Matutes E, Farahat N, et al. C-kit receptor (CD117) expression in acute leukemia. Ann Hematol 1996; 72:11-5.
45. Pinto A, Gloghini A, Gattei V, Aldinucci D, Zagonel V, Carbone A. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood 1994; 83:785-92.
46. Tomeczkowski J, Beilken A, Frick D, et al. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells. Blood 1995; 86:1469-80.
47. Ocqueteau M, Orfäo A, Garcia-Sanz R, Almeida J, Gonzalez M, San Miguel JF. Expression of the CD117 antigen (c-kit) on normal and myelomatous plasma cells. Br J Haematol 1996; 95:489-93.
48. Ikeda H, Kanakura Y, Tamaki T, et al. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 1991; 78:2962-8.
49. Broudy VC, Smith FO, Lin N, Zsebo KM, Egrie J, Bernstein ID. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 1992; 80:60-7.
50. Kubota A, Okamura S, Shimoda K, Harada M, Niho Y. The c-kit molecule and the surface immunophenotype of human acute leukemia. Leuk Lymphoma 1994; 14:421-8.
51. Reuss-Borst MA, Bühring HJ, Schmidt H, Müller CA. AML: immunophenotypte heterogeneity and prognostic significance of c-kit expression. Leukemia 1994; 8:258-63.
52. Smith FO, Broudy VC, Zsebo KM, et al. Cell surface expression of c-kit receptors by childhood acute myeloid leukemia blasts is not of prognostic value: a report from the Childrens Cancer Group. Blood 1994; 84:847-52.
53. Bradstock K, Matthews J, Benson E, Page F, Bishop J. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group. Blood 1994; 84:1220-5.
54. Lauria F, Bagnara GP, Rondelli D, et al. Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia. Leuk Lymphoma 1995;18:451-5.
55. Wells SJ, Bray RA, Stempora LL, Farhi DC. CD117/CD34 expression in leukemic blasts. Am J Clin Pathol 1996; 106:192-5.
56. Hirakawa K, Kimura S, Chikayama S, Misawa S, Maekawa T. Primary acute myeloid leukemia cells negative for c-kit receptor protein expression do not proliferate in vitro in response to colony-stimulating factors. Leukemia 1996; 10:279-87.
57. Cole SR, Aylett GW, Harvey NL, Cambareri AC, Ashman LK. Increased expression of c-kit or its ligand steel factor is not a common feature of adult acute myeloid leukaemia. Leukemia 1996; 10:258-96.
58. Wang C, Curtis JE, Geissler EN, McCulloch EA, Minden MD. The expression of the proto-oncogene c-kit in the blast cells of acute myeloblastic leukemia. Leukemia 1989; 3:699-702.
59. Venditti A, Del Poeta G, Buccisano F, et al. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes. Blood 1997; 89:621-9.
60. Sperling C, Schwartz S, Maurer J, et al. CD117 expression is restricted to myeloid and early T-lineage differentiation in acute leukemia and lacks prognostic significance in AML. Blood 1995; 86(suppl 1):40a.
61. Di Noto R, Lo Pardo C, Schiavone EM, et al. Stem cell factor receptor (c-kit, CD117) is expressed on blast cells from most immature types of acute myeloid malignancies but is also a characteristic of a subset of acute promyelocytic leukaemia. Br J Haematol 1996; 92:562-4.
62. Creutzig U, Harbott J, Sperling C, et al. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood 1995; 86:3097-108.
63. Ashman LK, Roberts MM, Gadd SJ, Cooper SJ, Juttner CA. Expression of a 150-kD cell surface antigen identified by monoclonal antibody YB5.B8 is associated with poor prognosis in acute non-lymphoblastic leukaemia. Leuk Res 1988; 12:923-8.
64. Büchner T, Hiddemann W, Löffler H, et al. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy for acute myeloid leukemia (AML): data from the AML Cooperative Group. Semin Hematol 1991; 28:76-9.
65. Murai K, Amemiya Y, Miura Y. Specificity of CD117 expression in the diagnosis of acute myeloid leukemia. Leukemia 1996; 10:1048.
66. Bené MC, Bernier M, Castoldi G, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995; 9:1783-6.
67. Nishii K, Kita K, Miwa H, et al. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen C013. Leukemia 1992; 6:662-8.
68. Knapp W, Strobl H, Majdic O. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 1994; 18:187-98.
69. Kees UR, Ashman LK. Synergistic action of interfeulcin-2 and Steel factor (SLF) on a human T lymphoblastoid cell line. Leukemia 1995; 9:1046-50.
70. Lanza F, Moretti S, Castagnari B, Latorraca A, Ferrarai L. Castoldi GL. Flow cytometry quantitation of IL3 and c-kit receptors in acute leukemias: clinical and biological implications [abstract]. Haematologica 1996; 81(suppl. to. n.5:80).